F. Samson , B. Cagnard , E. Leray , P. Guggenbuhl , L. Bridoux-Henno , A. Dabadie
{"title":"克罗恩病诊断后儿童骨密度的纵向研究","authors":"F. Samson , B. Cagnard , E. Leray , P. Guggenbuhl , L. Bridoux-Henno , A. Dabadie","doi":"10.1016/j.gcb.2010.01.024","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><p>The purpose of this study was to measure the bone mineral density (BMD) of children with Crohn's disease (CD) and to prospectively assess its evolution.</p></div><div><h3>Patients and methods</h3><p>A total of 27 children (20 boys, seven girls), aged 12.1<!--> <!-->±<!--> <!-->2.5 years, were recruited at the time of CD diagnosis. Dual-energy X-ray absorptiometry (DEXA) was used to measure BMD, expressed as Z scores for chronological age (BMD/CA) and bone age (BMD/BA). One year later, BMD was measured again to identify any correlations with disease activity [group A (active disease) vs group R (remission)].</p></div><div><h3>Results</h3><p>BMD/CA and BMD/BA were negatively correlated with delay in diagnosis (<em>P</em> <!--><<!--> <!-->0.0001 and <em>P</em> <!--><<!--> <!-->0.05, respectively). BMD/CA was less than −2 standard deviation (SD) in nine patients and BMD/BA was less −2 SD in four patients. At the follow-up, the increase in BMD was smaller in group A (<em>n</em> <!-->=<!--> <!-->14), whether expressed as absolute values (−0.002 vs 0.040<!--> <!-->g/cm<sup>2</sup> per year; <em>P</em> <!--><<!--> <!-->0.024) or as percentages (−0.2 vs 6.6%; <em>P</em> <!--><<!--> <!-->0.041); changes in BMD/CA (−0.5 vs −0.1 SD/year) and BMD/BA (−0.3 vs 0 SD/year) did not differ.</p></div><div><h3>Conclusion</h3><p>Diagnostic delay greatly affects BMD in children with CD even prior to corticosteroid therapy. The risk of low BMD increases with persistent CD activity, although the risk is reduced in association with bone maturation delay.</p></div>","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 10","pages":"Pages 554-561"},"PeriodicalIF":0.0000,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2010.01.024","citationCount":"7","resultStr":"{\"title\":\"Longitudinal study of bone mineral density in children after a diagnosis of Crohn's disease\",\"authors\":\"F. Samson , B. Cagnard , E. Leray , P. Guggenbuhl , L. Bridoux-Henno , A. Dabadie\",\"doi\":\"10.1016/j.gcb.2010.01.024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aim</h3><p>The purpose of this study was to measure the bone mineral density (BMD) of children with Crohn's disease (CD) and to prospectively assess its evolution.</p></div><div><h3>Patients and methods</h3><p>A total of 27 children (20 boys, seven girls), aged 12.1<!--> <!-->±<!--> <!-->2.5 years, were recruited at the time of CD diagnosis. Dual-energy X-ray absorptiometry (DEXA) was used to measure BMD, expressed as Z scores for chronological age (BMD/CA) and bone age (BMD/BA). One year later, BMD was measured again to identify any correlations with disease activity [group A (active disease) vs group R (remission)].</p></div><div><h3>Results</h3><p>BMD/CA and BMD/BA were negatively correlated with delay in diagnosis (<em>P</em> <!--><<!--> <!-->0.0001 and <em>P</em> <!--><<!--> <!-->0.05, respectively). BMD/CA was less than −2 standard deviation (SD) in nine patients and BMD/BA was less −2 SD in four patients. At the follow-up, the increase in BMD was smaller in group A (<em>n</em> <!-->=<!--> <!-->14), whether expressed as absolute values (−0.002 vs 0.040<!--> <!-->g/cm<sup>2</sup> per year; <em>P</em> <!--><<!--> <!-->0.024) or as percentages (−0.2 vs 6.6%; <em>P</em> <!--><<!--> <!-->0.041); changes in BMD/CA (−0.5 vs −0.1 SD/year) and BMD/BA (−0.3 vs 0 SD/year) did not differ.</p></div><div><h3>Conclusion</h3><p>Diagnostic delay greatly affects BMD in children with CD even prior to corticosteroid therapy. The risk of low BMD increases with persistent CD activity, although the risk is reduced in association with bone maturation delay.</p></div>\",\"PeriodicalId\":12508,\"journal\":{\"name\":\"Gastroenterologie Clinique Et Biologique\",\"volume\":\"34 10\",\"pages\":\"Pages 554-561\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.gcb.2010.01.024\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gastroenterologie Clinique Et Biologique\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S039983201000271X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastroenterologie Clinique Et Biologique","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S039983201000271X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
摘要
目的本研究的目的是测量克罗恩病(CD)儿童的骨密度(BMD),并对其演变进行前瞻性评估。患者和方法共招募27名儿童(男孩20名,女孩7名),年龄12.1±2.5岁。采用双能x线骨密度仪(DEXA)测量骨密度,以实足年龄(BMD/CA)和骨年龄(BMD/BA) Z分数表示。一年后,再次测量BMD以确定与疾病活动性的相关性[A组(活动性疾病)vs R组(缓解)]。结果BMD/CA、BMD/BA与诊断延误呈负相关(P <0.0001和P <分别为0.05)。9例患者BMD/CA小于- 2标准差(SD), 4例患者BMD/BA小于- 2标准差。在随访中,无论以绝对值表示(- 0.002 vs 0.040 g/cm2 /年;P & lt;0.024)或以百分比表示(- 0.2 vs 6.6%;P & lt;0.041);BMD/CA (- 0.5 vs - 0.1 SD/年)和BMD/BA (- 0.3 vs 0 SD/年)的变化没有差异。结论即使在皮质类固醇治疗之前,诊断延迟也会严重影响CD患儿的骨密度。低骨密度的风险随着持续的乳糜泻活动而增加,尽管与骨成熟延迟相关的风险降低。
Longitudinal study of bone mineral density in children after a diagnosis of Crohn's disease
Aim
The purpose of this study was to measure the bone mineral density (BMD) of children with Crohn's disease (CD) and to prospectively assess its evolution.
Patients and methods
A total of 27 children (20 boys, seven girls), aged 12.1 ± 2.5 years, were recruited at the time of CD diagnosis. Dual-energy X-ray absorptiometry (DEXA) was used to measure BMD, expressed as Z scores for chronological age (BMD/CA) and bone age (BMD/BA). One year later, BMD was measured again to identify any correlations with disease activity [group A (active disease) vs group R (remission)].
Results
BMD/CA and BMD/BA were negatively correlated with delay in diagnosis (P < 0.0001 and P < 0.05, respectively). BMD/CA was less than −2 standard deviation (SD) in nine patients and BMD/BA was less −2 SD in four patients. At the follow-up, the increase in BMD was smaller in group A (n = 14), whether expressed as absolute values (−0.002 vs 0.040 g/cm2 per year; P < 0.024) or as percentages (−0.2 vs 6.6%; P < 0.041); changes in BMD/CA (−0.5 vs −0.1 SD/year) and BMD/BA (−0.3 vs 0 SD/year) did not differ.
Conclusion
Diagnostic delay greatly affects BMD in children with CD even prior to corticosteroid therapy. The risk of low BMD increases with persistent CD activity, although the risk is reduced in association with bone maturation delay.